Benzophenone derivatives showed dual anti-inflammatory and antiproliferative activities by inhibiting cox enzymes and promote cyclin e downregulation.
dc.contributor.author | Folquitto, Laís Regina dos Santos | |
dc.contributor.author | Souza, Thiago Belarmino de | |
dc.contributor.author | Januário, Jaqueline Pereira | |
dc.contributor.author | Nascimento, Isadora M. | |
dc.contributor.author | Brandão, Brenda Tavares de Vasconcelos | |
dc.contributor.author | Moreira, Maria E. C. | |
dc.contributor.author | Horvath, Renato de Oliveira | |
dc.contributor.author | Santos, Marcelo Henrique dos | |
dc.contributor.author | Coelho, Luiz Felipe Leomil | |
dc.contributor.author | Veloso, Marcia Paranho | |
dc.contributor.author | Soares, Marisi Gomes | |
dc.contributor.author | Carvalho, Diogo Teixeira | |
dc.contributor.author | Ionta, Marisa | |
dc.contributor.author | Paula, Daniela Aparecida Chagas de | |
dc.contributor.author | Dias, Danielle Ferreira | |
dc.date.accessioned | 2022-12-07T20:10:50Z | |
dc.date.available | 2022-12-07T20:10:50Z | |
dc.date.issued | 2022 | pt_BR |
dc.description.abstract | Considering the promising antitumor effects of compounds with dual anti-inflammatory and antiproliferative activities, thus benzophenones analogs (2-7) were evaluated on in vivo anti- inflammatory assay and molecular docking analysis. Those with the best molecular docking results were in vitro evaluated on cyclooxygenase (COX) enzymes and tested regarding antiproliferative activity. All derivatives displayed in vivo anti-inflammatory activity. Among them, the substances 2’-hydroxy-4’-benzoylphenyl-β-D-glucopyranoside (4), 4-hydroxy-4’-methoxybenzophenone (5) and 4’-(4’’-methoxybenzoyl)phenyl-β-D-glucopyranoside (7)showed the best values of Glide Score in COX-2 docking evaluation and 4 and 5 selectively inhibited COX-2 and COX-1 in vitro enzymatic assay, respectively. Thus, 4 and 5 were tested against breast cancer (MCF-7, MDA-MB-231, Hs578T) and non-small-cell-lung cancer (A549) cell lines. The estrogen-positive MCF-7 cell line was more responsive compared to other tested cell lines. They induced cell cycle arrest at G1/S transition in MCF-7 cell line once there was an increase in G0/G1 population with concomitant reduction of S population. The antiproliferative activity of these substances on MCF-7 was associated with their ability to inhibit cyclin E expression, a critical regulator of G1/S transition. Taken together, the data indicate that 4 and 5 have dual anti-inflammatory and antiproliferative activities and support further studies to evaluate their antitumor potential. | pt_BR |
dc.identifier.citation | FOLQUITTO, L. R. dos S. et al. Benzophenone derivatives showed dual anti-inflammatory and antiproliferative activities by inhibiting cox enzymes and promote cyclin e downregulation. Journal of The Brazilian Chemical Society, v. 33, n. 4, 2022. Disponível em: <https://www.scielo.br/j/jbchs/a/vQWfZ7vcwWjt8bHCnpVSydR/>. Acesso em: 11 out. 2022. | pt_BR |
dc.identifier.doi | https://doi.org/10.21577/0103-5053.20210154 | pt_BR |
dc.identifier.issn | 1678-4790 | |
dc.identifier.uri | http://www.repositorio.ufop.br/jspui/handle/123456789/15877 | |
dc.language.iso | en_US | pt_BR |
dc.rights | aberto | pt_BR |
dc.rights.license | This is an open-access article distributed under the terms of the Creative Commons Attribution License. Fonte: o PDF do artigo. | pt_BR |
dc.subject | Molecular docking | pt_BR |
dc.subject | Ear edema | pt_BR |
dc.subject | Breast cancer | pt_BR |
dc.subject | Triple-negative | pt_BR |
dc.title | Benzophenone derivatives showed dual anti-inflammatory and antiproliferative activities by inhibiting cox enzymes and promote cyclin e downregulation. | pt_BR |
dc.type | Artigo publicado em periodico | pt_BR |
Files
Original bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- ARTIGO_BenzophenoneDerivativesShowed.pdf
- Size:
- 1.52 MB
- Format:
- Adobe Portable Document Format
- Description:
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: